Works matching IS 10031057 AND DT 2023 AND VI 32 AND IP 4

Results: 12

The team of Prof. Luwen Shi/Prof. Xiaodong Guan made research progress in the clinical benefit analysis of essential drugs for children cancer.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 331
Publication type:: Article

The team of Prof. Luwen Shi/Prof. Xiaodong Guan made research progress in the field of rational use of antibiotics.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 328
Publication type:: Article

The research team of Prof. Ming Ma has made new progress in the formation mechanism and structural diversity expansion of Polycyclic Sesquiterpenes.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 325
Publication type:: Article

The research team of Prof. Qing Xia published the experimental scheme of the treatment of rare diseases by the engineered tRNA-enzyme orthogonal system.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 322
Publication type:: Article

Influencing factors of generic drug substitution in China--from the perspective of psychiatric patients in "4 + 7" pilot cities.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 317, doi. 10.5246/jcps.2023.04.028

By:

Wenxia Liu;
Jun Ma;
Zhao Yang;
Bin Jiang

Publication type:

Article

Preliminary study of the mechanism underlying how Jianshen granules ameliorate renal failure in 5/6 nephrectomy model rats.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 302, doi. 10.5246/jcps.2023.04.027

By:

Haiying Qiu;
Mengdi Zhang;
Haiyan Jia;
Menglu Zhou;
Hongjie Lu;
Yan Wu

Publication type:

Article

The efficacy and safety of immune checkpoint inhibitors in malignant pleural mesothelioma: A systematic review.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 291, doi. 10.5246/jcps.2023.04.026

By:

Chonghao Wu;
Panjie Huang;
Chunqi Yang;
Chuan Gao;
Ming Zeng

Publication type:

Article

Chemical constituents from the calli of Maytenus hookeri.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 283, doi. 10.5246/jcps.2023.04.025

By:

Lei Jiang;
Yujiao Tu;
Weihua Dai;
Lin Yuan

Publication type:

Article

Study on the mechanism of Mongolian medicine Herba Lomatognii against acute liver injury based on network pharmacology.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 268, doi. 10.5246/jcps.2023.04.024

By:

Min Ao;
Minglan Bao;
Yaxing Hou;
Ying Yue;
Huifang Li;
Guohua Wu;
Su Ri Ga La Tu

Publication type:

Article

Acetylcholine ameliorates inflammatory microenvironment via regulating the balance of IL-1β/IL-1RA.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 260, doi. 10.5246/jcps.2023.04.023

By:

Ning Ma;
Chao Ji

Publication type:

Article

Overexpression of hBD3 inhibits cell proliferation, cell cycle, and migration in colon cancer cells.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 250, doi. 10.5246/jcps.2023.04.022

By:

Yancong Zhao;
Huiyuan Gong;
Jinghua Li

Publication type:

Article

In vitro blood-brain barrier models from different species: an overview on permeability associated with drug delivery.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 4, p. 237, doi. 10.5246/jcps.2023.04.021

By:

Wenjing Ta;
Ruochen Hua;
Xingyue Li;
Jihong Song;
Wen Lu

Publication type:

Article